AbbVie (ABBV) Down 2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 08/30/20
AbbVie Submits Regulatory Application to FDA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Ankylosing SpondylitisPRNewsWire • 08/25/20
AbbVie, Harvard University Form Research Alliance to Address Emergent Viral DiseasesPRNewsWire • 08/25/20
If You Like Attractively Valued Blue-Chips, You'll Love These 7 Dividend Growth StocksSeeking Alpha • 08/19/20